ARC logo.png
Payment Gateway Market Value Anticipated To Reach US$ 90.5 Billion By 2028 Covering Covid-19 Analysis: Acumen Research and Consulting
July 14, 2021 10:29 ET | Acumen Research and Consulting
LOS ANGELES, July 14, 2021 (GLOBE NEWSWIRE) -- The Payment Gateway Market is expected to grow at a CAGR of around 12.6% from 2021 to 2028 and reach the market value of over US$ 90.5 Bn by 2028. ...
High Volume Manufacturing of Gateway-Class SSPAs for LEO Constellation
Gilat Awarded $9 Million in Orders for Support of Low Earth Orbit Constellation
June 28, 2021 07:07 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, June 28, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services,...
Gilat-SSPA-2021
Gilat Awarded Over $4 Million in Orders for Support of Low Earth Orbit Constellation
May 20, 2021 07:08 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, May 20, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services,...
Gilat-Chile+Telefonica-2021 v2
Telefonica Global Solutions (TGS) Selects Gilat to Equip Strategic Teleport in Arica, Chile
May 11, 2021 07:03 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, May 11, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services,...
Gilat Satellite Networks Logo
Gilat Awarded Over $20 Million in Orders for Support of Low Earth Orbit Constellation
April 19, 2021 07:08 ET | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, April 19, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services,...
Vivet Therapeutics y Pfizer Inc reciben autorización de la FDA para iniciar GATEWAY, ensayo clínico de fase 1/2 con VTX-801, la terapia génica de Vivet para la enfermedad de Wilson
November 18, 2020 01:00 ET | Vivet Therapeutics
                                                                                                                                                    Vivet Therapeutics y Pfizer Inc reciben...
Vivet Therapeutics et Pfizer Inc. annoncent l’autorisation de la FDA de commencer l’étude de Phase 1/2 du VTX-801, GATEWAY, la thérapie génique expérimentale de Vivet pour la maladie de Wilson
November 18, 2020 01:00 ET | Vivet Therapeutics
                                                                                                                                                                                                        ...
Vivet Therapeutics and Pfizer Inc. Announce FDA Authorization to Proceed with GATEWAY, the Phase 1/2 Study for VTX-801, Vivet’s Investigational Gene Therapy for Wilson Disease
November 18, 2020 01:00 ET | Vivet Therapeutics
                                                                                                                                            Vivet Therapeutics and Pfizer...
ElectraMeccanica Logo 2020 (blue with bull) (002).jpg
ElectraMeccanica Partners with Gateway to Lead Expanded Investor Relations Program
June 23, 2020 08:31 ET | ElectraMeccanica Vehicles Corp.
VANCOUVER, British Columbia, June 23, 2020 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (“ElectraMeccanica” or the “Company”), a designer and manufacturer of electric vehicles,...
lantronix_logo_tagline_lo-res.jpg
Lantronix to Showcase Its EMG-Edge Management Gateway at Cisco Live in Barcelona
January 23, 2020 06:00 ET | Lantronix, Inc.
BARCELONA, Spain, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Lantronix, Inc. (NASDAQ: LTRX), a global provider of secure data access and management solutions for the industrial Internet of Things (IoT), will...